The Market Reports

Index

1 Anti-PD-1 MAb Market Overview
1.1 Product Overview and Scope of Anti-PD-1 MAb
1.2 Anti-PD-1 MAb Segment by Type
1.2.1 Global Anti-PD-1 MAb Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 40mg
1.2.3 100mg
1.2.4 200mg
1.2.5 Others
1.3 Anti-PD-1 MAb Segment by Application
1.3.1 Anti-PD-1 MAb Sales Comparison by Application: (2021-2027)
1.3.2 Melanoma Patients
1.3.3 Lung Cancer Patients
1.3.4 Lymphoma Patients
1.3.5 Other
1.4 Global Anti-PD-1 MAb Market Size Estimates and Forecasts
1.4.1 Global Anti-PD-1 MAb Revenue 2016-2027
1.4.2 Global Anti-PD-1 MAb Sales 2016-2027
1.4.3 Anti-PD-1 MAb Market Size by Region: 2016 Versus 2021 Versus 2027

2 Anti-PD-1 MAb Market Competition by Manufacturers
2.1 Global Anti-PD-1 MAb Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anti-PD-1 MAb Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anti-PD-1 MAb Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anti-PD-1 MAb Manufacturing Sites, Area Served, Product Type
2.5 Anti-PD-1 MAb Market Competitive Situation and Trends
2.5.1 Anti-PD-1 MAb Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-PD-1 MAb Players Market Share by Revenue
2.5.3 Global Anti-PD-1 MAb Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anti-PD-1 MAb Retrospective Market Scenario by Region
3.1 Global Anti-PD-1 MAb Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Anti-PD-1 MAb Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Anti-PD-1 MAb Market Facts & Figures by Country
3.3.1 North America Anti-PD-1 MAb Sales by Country
3.3.2 North America Anti-PD-1 MAb Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-PD-1 MAb Market Facts & Figures by Country
3.4.1 Europe Anti-PD-1 MAb Sales by Country
3.4.2 Europe Anti-PD-1 MAb Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-PD-1 MAb Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-PD-1 MAb Sales by Region
3.5.2 Asia Pacific Anti-PD-1 MAb Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-PD-1 MAb Market Facts & Figures by Country
3.6.1 Latin America Anti-PD-1 MAb Sales by Country
3.6.2 Latin America Anti-PD-1 MAb Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-PD-1 MAb Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-PD-1 MAb Sales by Country
3.7.2 Middle East and Africa Anti-PD-1 MAb Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Anti-PD-1 MAb Historic Market Analysis by Type
4.1 Global Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
4.2 Global Anti-PD-1 MAb Revenue Market Share by Type (2016-2021)
4.3 Global Anti-PD-1 MAb Price by Type (2016-2021)

5 Global Anti-PD-1 MAb Historic Market Analysis by Application
5.1 Global Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
5.2 Global Anti-PD-1 MAb Revenue Market Share by Application (2016-2021)
5.3 Global Anti-PD-1 MAb Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Corporation Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bristol Myers Squibb Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Junshi Pharma
6.3.1 Junshi Pharma Corporation Information
6.3.2 Junshi Pharma Description and Business Overview
6.3.3 Junshi Pharma Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Junshi Pharma Product Portfolio
6.3.5 Junshi Pharma Recent Developments/Updates
6.4 Innovent Biologics Inc
6.4.1 Innovent Biologics Inc Corporation Information
6.4.2 Innovent Biologics Inc Description and Business Overview
6.4.3 Innovent Biologics Inc Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Innovent Biologics Inc Product Portfolio
6.4.5 Innovent Biologics Inc Recent Developments/Updates
6.5 Hengrui Medicine
6.5.1 Hengrui Medicine Corporation Information
6.5.2 Hengrui Medicine Description and Business Overview
6.5.3 Hengrui Medicine Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Hengrui Medicine Product Portfolio
6.5.5 Hengrui Medicine Recent Developments/Updates
6.6 Beijing Beigene
6.6.1 Beijing Beigene Corporation Information
6.6.2 Beijing Beigene Description and Business Overview
6.6.3 Beijing Beigene Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Beijing Beigene Product Portfolio
6.6.5 Beijing Beigene Recent Developments/Updates

7 Anti-PD-1 MAb Manufacturing Cost Analysis
7.1 Anti-PD-1 MAb Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-PD-1 MAb
7.4 Anti-PD-1 MAb Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-PD-1 MAb Distributors List
8.3 Anti-PD-1 MAb Customers

9 Anti-PD-1 MAb Market Dynamics
9.1 Anti-PD-1 MAb Industry Trends
9.2 Anti-PD-1 MAb Growth Drivers
9.3 Anti-PD-1 MAb Market Challenges
9.4 Anti-PD-1 MAb Market Restraints

10 Global Market Forecast
10.1 Anti-PD-1 MAb Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-PD-1 MAb by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anti-PD-1 MAb by Type (2022-2027)
10.2 Anti-PD-1 MAb Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-PD-1 MAb by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anti-PD-1 MAb by Application (2022-2027)
10.3 Anti-PD-1 MAb Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-PD-1 MAb by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anti-PD-1 MAb by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Anti-PD-1 MAb Sales (KG) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Anti-PD-1 MAb Sales (KG) Comparison by Application (2021-2027)
Table 3. Global Anti-PD-1 MAb Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Anti-PD-1 MAb Covered in This Study
Table 5. Global Anti-PD-1 MAb Sales (KG) of Key Manufacturers (2016-2021)
Table 6. Global Anti-PD-1 MAb Sales Share by Manufacturers (2016-2021)
Table 7. Global Anti-PD-1 MAb Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Anti-PD-1 MAb Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Anti-PD-1 MAb Average Price (USD/KG) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Anti-PD-1 MAb Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-PD-1 MAb Product Type
Table 12. Global Anti-PD-1 MAb Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-PD-1 MAb by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-PD-1 MAb as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-PD-1 MAb Sales by Region (2016-2021) & (KG)
Table 16. Global Anti-PD-1 MAb Sales Market Share by Region (2016-2021)
Table 17. Global Anti-PD-1 MAb Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Anti-PD-1 MAb Sales by Country (2016-2021) & (KG)
Table 19. North America Anti-PD-1 MAb Sales Market Share by Country (2016-2021)
Table 20. North America Anti-PD-1 MAb Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Anti-PD-1 MAb Revenue Market Share by Country (2016-2021)
Table 22. Europe Anti-PD-1 MAb Sales by Country (2016-2021) & (KG)
Table 23. Europe Anti-PD-1 MAb Sales Market Share by Country (2016-2021)
Table 24. Europe Anti-PD-1 MAb Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Anti-PD-1 MAb Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Anti-PD-1 MAb Sales by Region (2016-2021) & (KG)
Table 27. Asia Pacific Anti-PD-1 MAb Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Anti-PD-1 MAb Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Anti-PD-1 MAb Revenue Market Share by Region (2016-2021)
Table 30. Latin America Anti-PD-1 MAb Sales by Country (2016-2021) & (KG)
Table 31. Latin America Anti-PD-1 MAb Sales Market Share by Country (2016-2021)
Table 32. Latin America Anti-PD-1 MAb Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Anti-PD-1 MAb Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Anti-PD-1 MAb Sales by Country (2016-2021) & (KG)
Table 35. Middle East and Africa Anti-PD-1 MAb Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Anti-PD-1 MAb Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Anti-PD-1 MAb Revenue Market Share by Country (2016-2021)
Table 38. Global Anti-PD-1 MAb Sales (KG) by Type (2016-2021)
Table 39. Global Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
Table 40. Global Anti-PD-1 MAb Revenue (Million US$) by Type (2016-2021)
Table 41. Global Anti-PD-1 MAb Revenue Share by Type (2016-2021)
Table 42. Global Anti-PD-1 MAb Price (USD/KG) by Type (2016-2021)
Table 43. Global Anti-PD-1 MAb Sales (KG) by Application (2016-2021)
Table 44. Global Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
Table 45. Global Anti-PD-1 MAb Revenue (Million US$) by Application (2016-2021)
Table 46. Global Anti-PD-1 MAb Revenue Share by Application (2016-2021)
Table 47. Global Anti-PD-1 MAb Price (USD/KG) by Application (2016-2021)
Table 48. Bristol Myers Squibb Corporation Information
Table 49. Bristol Myers Squibb Description and Business Overview
Table 50. Bristol Myers Squibb Anti-PD-1 MAb Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 51. Bristol Myers Squibb Anti-PD-1 MAb Product
Table 52. Bristol Myers Squibb Recent Developments/Updates
Table 53. Merck Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Anti-PD-1 MAb Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 56. Merck Anti-PD-1 MAb Product
Table 57. Merck Recent Developments/Updates
Table 58. Junshi Pharma Corporation Information
Table 59. Junshi Pharma Description and Business Overview
Table 60. Junshi Pharma Anti-PD-1 MAb Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 61. Junshi Pharma Anti-PD-1 MAb Product
Table 62. Junshi Pharma Recent Developments/Updates
Table 63. Innovent Biologics Inc Corporation Information
Table 64. Innovent Biologics Inc Description and Business Overview
Table 65. Innovent Biologics Inc Anti-PD-1 MAb Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 66. Innovent Biologics Inc Anti-PD-1 MAb Product
Table 67. Innovent Biologics Inc Recent Developments/Updates
Table 68. Hengrui Medicine Corporation Information
Table 69. Hengrui Medicine Description and Business Overview
Table 70. Hengrui Medicine Anti-PD-1 MAb Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 71. Hengrui Medicine Anti-PD-1 MAb Product
Table 72. Hengrui Medicine Recent Developments/Updates
Table 73. Beijing Beigene Corporation Information
Table 74. Beijing Beigene Description and Business Overview
Table 75. Beijing Beigene Anti-PD-1 MAb Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 76. Beijing Beigene Anti-PD-1 MAb Product
Table 77. Beijing Beigene Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Anti-PD-1 MAb Distributors List
Table 81. Anti-PD-1 MAb Customers List
Table 82. Anti-PD-1 MAb Market Trends
Table 83. Anti-PD-1 MAb Growth Drivers
Table 84. Anti-PD-1 MAb Market Restraints
Table 85. Global Anti-PD-1 MAb Sales Forecast by Type (2022-2027) & (KG)
Table 86. Global Anti-PD-1 MAb Sales Market Share Forecast by Type (2022-2027)
Table 87. Global Anti-PD-1 MAb Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 88. Global Anti-PD-1 MAb Revenue Market Share Forecast by Type (2022-2027)
Table 89. Global Anti-PD-1 MAb Sales Forecast by Application (2022-2027) & (KG)
Table 90. Global Anti-PD-1 MAb Sales Market Share Forecast by Application (2022-2027)
Table 91. Global Anti-PD-1 MAb Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 92. Global Anti-PD-1 MAb Revenue Market Share Forecast by Application (2022-2027)
Table 93. Global Anti-PD-1 MAb Sales Forecast by Region (2022-2027) & (KG)
Table 94. Global Anti-PD-1 MAb Sales Market Share Forecast by Region (2022-2027)
Table 95. Global Anti-PD-1 MAb Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 96. Global Anti-PD-1 MAb Revenue Market Share Forecast by Region (2022-2027)
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-PD-1 MAb
Figure 2. Global Anti-PD-1 MAb Market Share by Type in 2020 & 2027
Figure 3. 40mg Product Picture
Figure 4. 100mg Product Picture
Figure 5. 200mg Product Picture
Figure 6. Others Product Picture
Figure 7. Global Anti-PD-1 MAb Market Share by Application in 2020 & 2027
Figure 8. Melanoma Patients
Figure 9. Lung Cancer Patients
Figure 10. Lymphoma Patients
Figure 11. Other
Figure 12. Global Anti-PD-1 MAb Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Anti-PD-1 MAb Market Size 2016-2027 (US$ Million)
Figure 14. Global Anti-PD-1 MAb Sales 2016-2027 (KG)
Figure 15. Global Anti-PD-1 MAb Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Anti-PD-1 MAb Sales Share by Manufacturers in 2020
Figure 17. Global Anti-PD-1 MAb Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Anti-PD-1 MAb Players: Market Share by Revenue in 2020
Figure 19. Anti-PD-1 MAb Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Anti-PD-1 MAb Sales Market Share by Region (2016-2021)
Figure 21. Global Anti-PD-1 MAb Sales Market Share by Region in 2020
Figure 22. Global Anti-PD-1 MAb Revenue Market Share by Region (2016-2021)
Figure 23. Global Anti-PD-1 MAb Revenue Market Share by Region in 2020
Figure 24. U.S. Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Anti-PD-1 MAb Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Anti-PD-1 MAb by Type (2016-2021)
Figure 49. Sales Market Share of Anti-PD-1 MAb by Application (2016-2021)
Figure 50. Sales Market Share of Anti-PD-1 MAb by Application in 2020
Figure 51. Revenue Share of Anti-PD-1 MAb by Application (2016-2021)
Figure 52. Revenue Share of Anti-PD-1 MAb by Application in 2020
Figure 53. Manufacturing Cost Structure of Anti-PD-1 MAb
Figure 54. Manufacturing Process Analysis of Anti-PD-1 MAb
Figure 55. Anti-PD-1 MAb Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed